HDAC9 and amyotrophic lateral sclerosis: Finally, an in vivo brain assessment of HDAC alterations by positron emission tomography showed no significant differences in HDAC expression levels between ALS patients and healthy controls [81], suggesting that HDAC alterations may have a more profound effect on the disease in peripheral tissues.